Literature DB >> 22920004

Neurologic manifestations of hypereosinophilic syndrome--review of the literature.

Marina Titlić1, Katica Kodzoman, Dragan Loncar.   

Abstract

Hypereosinophilic syndrome is a rare disorder of the hematopoietic system. The disease is characterized by continuously high number of eosinophils (>1.5 x 10(9)/L) for more than six months. Other possible causes of hypereosinophilia, such as allergic and parasitic diseases, malignant disease, Churg-Strauss disease and infection should be eliminated. The most common manifestations of hypereosinophilic syndrome are pulmonary, skin, gastrointestinal, cardiac difficulties and neurologic lesions. Numerous neurologic lesions have been described, in particular of the central and peripheral nervous systems. Review of the literature revealed the following to have been recorded so far: mononeuritis multiplex, sensory polyneuropathy, radiculopathy, myalgia, myositis and perimyositis, neuropathy, ataxia, paraplegia, ophthalmologic abnormalities, optic neuritis, hemiplegia-hemiparesis, spasmodic quadriplegia, seizures, meningitis, cerebral infarction, organic psychosyndrome, other mental changes, stroke, temporal arteritis, leptomeningeal dissemination, memory deficits and dysarthria.

Entities:  

Mesh:

Year:  2012        PMID: 22920004

Source DB:  PubMed          Journal:  Acta Clin Croat        ISSN: 0353-9466            Impact factor:   0.780


  3 in total

1.  Extensive myelitis with eosinophilic meningitis after Chimeric antigen receptor T cells therapy.

Authors:  Baptiste Le Calvez; Marion Eveillard; Paul Decamps; Jesus Aguilar; Amélie Seguin; Emmanuel Canet; Audrey Grain; Cyrille Touzeau; Benoît Tessoulin; Thomas Gastinne
Journal:  EJHaem       Date:  2022-02-01

2.  Identification of a novel PDGFRA point mutation at p.P6L as a potential molecular target of imatinib in an eosinophilia patient showing genetic heterogeneity.

Authors:  Miaomiao Zhao; Qiuling Wu; Linghui Xia; Min Zhang; Jianqing Yang; Yaya Li; Shichun Tu; Yadan Wang
Journal:  Cancer Biol Ther       Date:  2018-10-25       Impact factor: 4.742

3.  Eosinophils in hereditary and inflammatory myopathies.

Authors:  Thomas Schröder; Johann Fuchss; Ilka Schneider; Gisela Stoltenburg-Didinger; Frank Hanisch
Journal:  Acta Myol       Date:  2013-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.